BACKGROUND The early onset of menopause is associated with increased risks of
cardiovascular disease and osteoporosis. As a woman's circulating anti-Müllerian hormone …

BACKGROUND In women, anti-Müllerian hormone (AMH) is exclusively produced by
granulosa cells of ovarian follicles during the early stages of follicle development. After an …

Most aging individuals die from atherosclerosis, cancer, or dementia; but in the oldest old,
loss of muscle strength resulting in frailty is the limiting factor for an individual's chances of …

Context: Anti-Mullerian hormone (AMH) has emerged as a marker of ovarian reserve and a
possible surrogate measure of reproductive aging. Objective: The aim of the study was to …

Primary ovarian insufficiency (POI), also known as premature ovarian failure, is a disorder of
infertility characterized by amenorrhoea, low estrogen levels and increased gonadotropin …

Context: Anti-müllerian hormone (AMH) is an ovarian reserve marker that is increasingly
applied in clinical practice as a prognostic and diagnostic tool. Despite increased use of …

Background A test that helps predict the time to the final menstrual period (FMP) has been
sought for many years. Objective To assess the ability of antimullerian hormone (AMH) …

OBJECTIVE: To evaluate whether circulating levels of antimüllerian hormone (AMH) predict
fecundability in young healthy women. DESIGN: Prospective cohort study. SETTING …

Objective To examine the short-term effects of salpingectomy during laparoscopic
hysterectomy on ovarian reserve when ovarian preservation is planned in view of …

It remains controversial whether anti-Müllerian hormone (AMH) concentration is influenced
by hormonal contraception. This study quantified the effect of hormonal contraception on …